English | Español
Patient Daily | Jul 14, 2026

FDA proposes streamlined requirements for hub-and-spoke drug manufacturing networks
Patient Daily | Jul 14, 2026

Xeltis announces first commercial implant of aXess vascular access device in Europe
Patient Daily | Jul 14, 2026

Researchers explore dual drug therapy to combat obesity-driven leukemia progression
Patient Daily | Jul 14, 2026

South Korean researchers develop smart nanoparticles for targeted pancreatic cancer treatment
Patient Daily | Jul 14, 2026

Spero Therapeutics secures global rights to Innovent’s autoimmune antibody in $1.1 billion deal
Patient Daily | Jul 14, 2026

Report identifies top ten brain health breakthroughs for clinicians in 2025
Patient Daily | Jul 14, 2026

AstraZeneca secures global license for Dizal’s lung cancer drug in $1.5 billion deal
Patient Daily | Jul 14, 2026

BioSpace reviews Q2 2026 biopharma job market trends and outlook

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Regulatory
G. N. Ball | Aug 5, 2026

Citizens Against Government Waste on 340B: 'Covered hospitals now generate millions of dollars of profit'